Cargando…
The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting
BACKGROUND: Little is known about the pathway to diagnosis of lymphoma in Sub-Saharan Africa, despite the increased risk of lymphoma in people living with HIV (PLHIV). The challenges of diagnosis in this setting include diagnostic confusion with extrapulmonary tuberculosis (EPTB), which commonly cau...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485177/ https://www.ncbi.nlm.nih.gov/pubmed/31023278 http://dx.doi.org/10.1186/s12885-019-5586-4 |
_version_ | 1783414232658739200 |
---|---|
author | Antel, Katherine Levetan, Carly Mohamed, Zainab Louw, Vernon J Oosthuizen, Jenna Maartens, Gary Verburgh, Estelle |
author_facet | Antel, Katherine Levetan, Carly Mohamed, Zainab Louw, Vernon J Oosthuizen, Jenna Maartens, Gary Verburgh, Estelle |
author_sort | Antel, Katherine |
collection | PubMed |
description | BACKGROUND: Little is known about the pathway to diagnosis of lymphoma in Sub-Saharan Africa, despite the increased risk of lymphoma in people living with HIV (PLHIV). The challenges of diagnosis in this setting include diagnostic confusion with extrapulmonary tuberculosis (EPTB), which commonly causes lymphadenopathy in PLHIV. METHODS: We analysed the time to diagnosis and treatment in patients using predetermined time intervals. Univariate and multivariable analyses were performed to determine the relationship between patient and disease-specific variables with delays to diagnosis. We were particularly interested in the impact of HIV, empiric tuberculosis therapy and fine-needle aspirate for cytology (FNAC) in contributing to delay. RESULTS: Patients (n = 163), 29% HIV-infected, waited a median of 4 weeks before seeking medical attention. It took a median of 7 weeks for the diagnosis of lymphoma to be made from the time the patient sought medical attention, termed the healthcare practitioner interval. In multivariable logistic regression analysis, diagnostic delay > 6 weeks was associated with late-stage disease (OR 2.3, 95% CI 1.1–5.2) and Hodgkin lymphoma (HL) (OR 3.0, 95% CI 1.1–8.0). HIV status was not associated with diagnostic delay (OR 0.9, 95% CI 0.3–2.2). The median time to diagnosis was a median of 4 weeks longer for patients on tuberculous (TB) therapy (n = 16, p = 0.28) and patients who underwent an FNAC (n = 63, p = 0.04). Where FNAC was performed, it was diagnostic for lymphoma in only 11%. Diagnostic delay was not associated with overall survival. CONCLUSIONS: Time-to-diagnosis of lymphoma in South Africa was similar to that reported from high-income countries and shows significant periods of delay between the onset of symptoms to diagnosis and treatment. The longest period of delay was in the health practitioner interval. Education regarding the significance of lymphadenopathy for both patients and health care practitioners and appropriate investigative steps preferably by best-practice algorithms specific to TB-endemic areas are needed to shorten the time-to-diagnosis of lymphoma. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-5586-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6485177 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64851772019-05-03 The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting Antel, Katherine Levetan, Carly Mohamed, Zainab Louw, Vernon J Oosthuizen, Jenna Maartens, Gary Verburgh, Estelle BMC Cancer Research Article BACKGROUND: Little is known about the pathway to diagnosis of lymphoma in Sub-Saharan Africa, despite the increased risk of lymphoma in people living with HIV (PLHIV). The challenges of diagnosis in this setting include diagnostic confusion with extrapulmonary tuberculosis (EPTB), which commonly causes lymphadenopathy in PLHIV. METHODS: We analysed the time to diagnosis and treatment in patients using predetermined time intervals. Univariate and multivariable analyses were performed to determine the relationship between patient and disease-specific variables with delays to diagnosis. We were particularly interested in the impact of HIV, empiric tuberculosis therapy and fine-needle aspirate for cytology (FNAC) in contributing to delay. RESULTS: Patients (n = 163), 29% HIV-infected, waited a median of 4 weeks before seeking medical attention. It took a median of 7 weeks for the diagnosis of lymphoma to be made from the time the patient sought medical attention, termed the healthcare practitioner interval. In multivariable logistic regression analysis, diagnostic delay > 6 weeks was associated with late-stage disease (OR 2.3, 95% CI 1.1–5.2) and Hodgkin lymphoma (HL) (OR 3.0, 95% CI 1.1–8.0). HIV status was not associated with diagnostic delay (OR 0.9, 95% CI 0.3–2.2). The median time to diagnosis was a median of 4 weeks longer for patients on tuberculous (TB) therapy (n = 16, p = 0.28) and patients who underwent an FNAC (n = 63, p = 0.04). Where FNAC was performed, it was diagnostic for lymphoma in only 11%. Diagnostic delay was not associated with overall survival. CONCLUSIONS: Time-to-diagnosis of lymphoma in South Africa was similar to that reported from high-income countries and shows significant periods of delay between the onset of symptoms to diagnosis and treatment. The longest period of delay was in the health practitioner interval. Education regarding the significance of lymphadenopathy for both patients and health care practitioners and appropriate investigative steps preferably by best-practice algorithms specific to TB-endemic areas are needed to shorten the time-to-diagnosis of lymphoma. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-5586-4) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-25 /pmc/articles/PMC6485177/ /pubmed/31023278 http://dx.doi.org/10.1186/s12885-019-5586-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Antel, Katherine Levetan, Carly Mohamed, Zainab Louw, Vernon J Oosthuizen, Jenna Maartens, Gary Verburgh, Estelle The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting |
title | The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting |
title_full | The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting |
title_fullStr | The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting |
title_full_unstemmed | The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting |
title_short | The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting |
title_sort | determinants and impact of diagnostic delay in lymphoma in a tb and hiv endemic setting |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485177/ https://www.ncbi.nlm.nih.gov/pubmed/31023278 http://dx.doi.org/10.1186/s12885-019-5586-4 |
work_keys_str_mv | AT antelkatherine thedeterminantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting AT levetancarly thedeterminantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting AT mohamedzainab thedeterminantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting AT louwvernonj thedeterminantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting AT oosthuizenjenna thedeterminantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting AT maartensgary thedeterminantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting AT verburghestelle thedeterminantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting AT antelkatherine determinantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting AT levetancarly determinantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting AT mohamedzainab determinantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting AT louwvernonj determinantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting AT oosthuizenjenna determinantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting AT maartensgary determinantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting AT verburghestelle determinantsandimpactofdiagnosticdelayinlymphomainatbandhivendemicsetting |